GEORGE VAN BUREN to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications GEORGE VAN BUREN has written about Xenograft Model Antitumor Assays.
Connection Strength
0.151
-
Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver. Cancer. 2009 Jul 15; 115(14):3360-8.
Score: 0.066
-
Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft. JCI Insight. 2021 07 08; 6(13).
Score: 0.038
-
SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019 02 01; 442:310-319.
Score: 0.031
-
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene. 2008 Dec 04; 27(57):7192-200.
Score: 0.016